4//SEC Filing
Kelley Lynne E 4
Accession 0000899243-19-011289
CIK 0001501697other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 7:58 PM ET
Size
5.7 KB
Accession
0000899243-19-011289
Insider Transaction Report
Form 4
Kelley Lynne E
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2019-04-24+37,170→ 37,170 totalExercise: $20.30Exp: 2029-04-24→ Common Stock (37,170 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on April 24, 2020, with the remainder vesting in equal installments of 2.083% of the shares subject to the option on the last day of each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001667584
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 7:58 PM ET
- Size
- 5.7 KB